Cardiol Therapeutics Inc. (CRDL.TO)
Develops heart disease treatments using cannabidiol and anti-inflammatory drugs.
1.70+0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago-11.0%
The outlook
Cardiol Therapeutics (CRDL.TO) sits near the middle of its 52-week range at $1.70, trading above both its 50- and 200-day moving averages. The two analysts covering the stock hold a Strong Buy consensus with an average price target implying significant upside versus the current price. The overall technical and sentiment backdrop leans constructively.
What’s behind the score
Analyst consensusStrong Buy — 1.4 avg of 2 analysts
Price trendAbove its 50- & 200-day averages
52-week range43% of the way from its 52-week low to high
Price targetAvg target +253% vs current price
Analyst price target
~12-month · 2 analysts6.00average target+252.9% vs now
Now 1.70
Low 5.00High 7.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$196.0M
52-wk high
2.33
52-wk low
1.23
50-day avg
1.60
200-day avg
1.55
Trailing P/E
—